RGRodrigo Saar Gomes

Rodrigo Saar Gomes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rodrigo Saar Gomes has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Microencapsulated oxfendazole modulates neuroinflammation in experimental Taenia crassiceps neurocysticercosis

    by Anna Clara Lopes de Moura, Giselle Rocío Bedogni, Geovana Batista de Campos, Jessica Yonara de Souza, Rodrigo Saar Gomes, Ruy de Souza Lino Júnior, Claudio Javier Salomon, Marina Clare Vinaud

  • Open Access

    7-dehydrocholesterol reductase inhibitors control Leishmania spp. in human macrophages

    by Carlos Henrique da Silva Mota, Ana Marília Viana Utim, Wesley Lima de Paula, Geovanna Medeiros de Oliveira, Ana Luísa Macedo das Mercez Torres, Fátima Ribeiro-Dias, Rodrigo Saar Gomes

  • Open Access

    Characterization of T Helper 1 and 2 Cytokine Profiles in Newborns of Mothers with COVID-19

    by André Luís Elias Moreira, Paulo Alex Neves da Silva, Rodrigo Saar Gomes, Mônica de Oliveira Santos, Célia Regina Malveste Ito, Lucas Candido Gonçalves Barbosa, Paula Pires de Souza, Fernanda Aparecida de Oliveira Peixoto, Isabela Jubé Wastowski, Lilian Carla Carneiro, et al.

    An infectious disease caused by SARS-CoV-2, COVID-19 greatly affects the pediatric population and is 3 times more prevalent in newborns than in the general population. In newborns, the overexpression of immunological molecules may also induce a so-called cytokine storm. In our study, we evaluated the expression of cytokines in newborns admitted to a neonatal ICU whose mothers had SARS-CoV-2 and symptoms of SARS. The blood of newborns of infected and healthy mothers was collected to identify their Th1 and Th2 cytokine profiles, and via flow cytometry, the cytokines TNF-α, IFN-γ, IL-2, IL-6, and IL-10 were identified. Overexpression was observed in the Th1 and Th2 cytokine profiles of newborns from infected mothers compared with the control group. Statistical analysis also revealed significant differences between the cellular and humoral responses of the infected group versus the control group. The cellular versus humoral responses of the newborns of infected mothers were also compared, which revealed the prevalence of the cellular immune response. These data demonstrate that some cytokines identified relate to more severe symptoms and even some comorbidities. IL-6, TNF-α, and IL-10 may especially be related to cytokine storms in neonates of mothers with COVID-19.


  • The role of IL-32 in Bacillus Calmette-Guérin (BCG)-induced trained immunity in infections caused by different Leishmania spp.

    by Muriel Vilela Teodoro Silva, Jéssica Cristina dos Santos, Ana Marina Barroso de Figueiredo, Lisa U. Teufel, Jonathas Xavier Pereira, Grazzielle Guimarães de Matos, Sebastião Alves Pinto, Mihai G. Netea, Rodrigo Saar Gomes, Leo A.B. Joosten, et al.


  • Toll‐like receptor 10 controls TLR2‐induced cytokine production in monocytes from patients with Parkinson's disease

    by Hermínio Maurício da Rocha Sobrinho, Rodrigo Saar Gomes, Delson José da Silva, Valéria Bernadete Leite Quixabeira, Leo A. B. Joosten, Cristina Ribeiro de Barros Cardoso, Fátima Ribeiro‐Dias

    Peripheral inflammation, particularly mediated by monocytes, can cause neuroinflammation in Parkinson's disease (PD). We investigated the mechanism of TLR2‐induced cytokine impairment in peripheral monocytes from PD patients and the association between the presence of CD14+TLR10+ monocytes and PD severity. Peripheral blood mononuclear cells from PD patients and healthy individuals were evaluated for TLR expression on monocyte subsets (CD14 and CD16 expression) using flow cytometry. Moreover, cytokines were evaluated using flow cytometry after stimulation with Pam3Cys (TLR2/TLR1 agonist) in the absence or presence of neutralizing antibodies to TLR10. The severity of PD was assessed using the unified PD rating scale (UPDRS) and motor activity, anxiety (BAI), depression (BDI), and fatigue (PD Fatigue Scale‐16) scales. The frequency of CD14+TLR10+ monocytes and expression intensity of TLR2 and TLR10 were higher in patients with PD than healthy individuals. The frequency of intermediate monocytes (CD14++CD16+) was not significantly increased in patients with PD, but was the main monocyte subset expressing TLR10. The TLR2/TLR1‐impaired cytokine production (IL‐6, TNFα, IL‐8, and IL‐10) in PD patients was reversed by neutralizing TLR10. The high frequency of total CD14+TLR10+ monocytes was associated with a reduction in the severity of PD according to the evaluation of motor and nonmotor symptoms. Peripheral monocytes from patients with PD showed phenotypic and functional alterations. The expression of TLR10 on monocytes can protect against PD by controlling TLR2‐induced cytokine production. Furthermore, data suggested that a low frequency of CD14+TLR10+ monocytes indicates the severity of PD. The results identified new opportunities for the development of novel PD neuroprotective therapies.


  • Alterations in monocyte subsets and cytokine production after TLR activation in American Cutaneous Leishmaniasis

    by Valéria Bernadete Leite Quixabeira, Ledice Inacia de Araújo Pereira, Poliana Ribeiro Valadares Veras, Ana Carolina Vieira da Costa, Larissa Gomides Fonseca, Hélio Galdino Jr., Ildefonso Alves da Silva Jr., Camila Imai Morato, Sebastião Alves Pinto, Ana Joaquina Cohen Serique Pereira, et al.

    Phenotypic and functional aspects of monocytes from Localized Cutaneous Leishmaniasis (LCL) patients were evaluated. The frequencies of monocyte subsets and TLR2/TLR4 expression were evaluated in fresh peripheral blood whereas cytokine production was evaluated in whole blood cell cultures stimulated with TLR agonists or Leishmania braziliensis antigen (Ag). CD16+ monocytes frequency was increased in patients compared with controls. A TLR4 agonist (LPS) induced expression of TNF and IL‐10 in monocyte subsets of patients and controls. The CD14+CD16+ monocytes expressed higher levels of these cytokines than CD14+CD16− cells. The levels of secreted TNF were higher in whole blood cell cultures from patients than controls after LPS/TLR4 or Ag stimulation. Whereas in controls there was a positive correlation between TNF and IL‐10 levels, this was not observed in stimulated cell cultures from patients. The high levels of LPS‐induced TNF were associated with the number of lesions and the percentages of CD14hiCD16+ monocytes. The levels of TLR2‐induced TNF were also associated with number of lesions. All monocyte subsets from patients expressed higher levels of TLR2 and TLR4 than controls. Data suggest that systemically activated monocytes contribute for an imbalance in pro‐ and anti‐inflammatory cytokine production during LCL, participating in the immunopathogenesis of the disease.


  • Open Access

    IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis

    by Rodrigo Saar Gomes, Muriel Vilela Teodoro Silva, Jéssica Cristina dos Santos, Lucas Luiz de Lima Silva, Aline Carvalho Batista, Juliana Reis Machado, Mauro Martins Teixeira, Miriam Leandro Dorta, Milton Adriano Pelli de Oliveira, Charles A Dinarello, et al.

    Interleukin 32 (IL-32) is a pro-inflammatory cytokine induced in patients with American tegumentary leishmaniasis (ATL) caused by Leishmania braziliensis. Here, we investigated whether IL-32 is also expressed in patient lesions caused by L. amazonensis. In addition, we evaluated experimental L. amazonensis and L. braziliensis infections in C57BL/6 transgenic mice for human IL-32γ (IL-32γTg) in comparison with wild-type (WT) mice that do not express the IL-32 gene. Human cutaneous lesions caused by L. amazonensis express higher levels of IL-32 than healthy control skin. In mice, the presence of IL-32γ promoted the control of cutaneous lesions caused by L. braziliensis, but not lesions caused by L. amazonensis in an ear dermis infection model. In addition, IL-32γTg mice displayed less tissue parasitism and inflammation in IL-32γTg than WT mice during the healing phase of L. braziliensis infection. Production of antigen-specific pro-inflammatory cytokines was higher in IL-32γTg mice than in WT mice during L. braziliensis infection but not during L. amazonensis infection. Human cutaneous lesions caused by L. amazonensis express high levels of IL-32. In mice, the presence of IL-32γ contributes to the lesion healing caused by L. braziliensis but not by L. amazonensis. Data suggest that despite the ability for both species to induce IL-32 in humans, the connections between this cytokine and other immune players induced by related species of parasites can lead to distinct outcomes of the murine infections.